Not logged in...
About USC Norris
FAQ - Trials
Contact Us - Trials
Support USC Norris
» Contact Us
If you are a patient, please contact
Keck Medical Center of USC
MR Techniques in the Evaluation of Hepatocellular Carcinoma: Gadoxetate.
Closed to Accrual with Ongoing Follow-up
Defintions of terms and FAQ about clinical trials.
Gilbert Whang, M.D.
Other Trial Staff:
Andrea Contreras, Coordinator
to see study documents.
You may participate in this study if:
CT features suggestive of HCC – For an arterially-enhancing lesion = / > 1 cm, but < 2 cm, all of the following criteria must be met:  Imaging features of a mass;  Wash-out on later phases of contrast administration;  At least 1 cm or more growth. For an arterially-enhancing leason = / > 2 cm, two of the following criteria must be met:  Imaging features of a mass;  Wash-out on later phases of contrast administration;  At least 1 cm or more growth.
At least 18 years of age
Able to tolerate a complete abdominal MR examination within 3 weeks of CT
Signed an approved study-specific informed consent and HIPAA
You may not participate in this study if:
Unable to undergo MRI due to intraocular metallic foreign body, pacemaker, or other contraindications including objects in the body which are deemed to be unsafe or notable to be assessed, or unable to undergo MRI within 3 weeks of CT
Prior history of treatment of liver lesions
Severe renal insufficiency – estimated glomerular filtration rate of < 30 cc/min
Severe liver disease – Childs Class C Cirrhosis
History of a previous reaction to contrast media, bronchial asthma, or allergic disorders
Acute renal insufficiency of any severity due to the hepato-renal syndrome or in the peri-operative liver transplantation period
For further information on a study, please contact the Clinical Investigation Support Office at (323) 865-0451, or
To schedule a consultation with the hospital, please call our New Patient Referrals Office at (323) 865-3111.